FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
Abstract 3D molecular structures representing research peptides.

A reference index of research peptides

Mechanism, evidence, citations — one entry per compound.

Peer-reviewed sources. A–F evidence grades. PubMed cross-links. Research use only. See latest papers →

GIGARESEARCH · List of Peptides and What They Do · Research Peptide Encyclopedia

LIST OF PEPTIDES AND WHAT THEY DO · 27 REFERENCE INDEX
★TODAY'S FEATUREDNAD+→

▶ LIST OF 27 PEPTIDES · WHAT THEY DO + MECHANISM + EVIDENCE

TRI-RECEPTOR INCRETIN AGONIST molecular structure
No. 001
TRI-RECEPTOR INCRETIN AGONIST
METABOLICINCRETIN
GLP-1 / GIP DUAL AGONIST molecular structure
No. 002
GLP-1 / GIP DUAL AGONIST
METABOLICINCRETIN
BPC-157 molecular structure
No. 003
BPC-157
REGENCYTOPROTECTION
GHK-Cu molecular structure
No. 004
GHK-Cu
REGENLONGEVITY
KLOW BLEND molecular structure
No. 005
KLOW BLEND
MULTI
NAD+ molecular structure
No. 006
NAD+
LONGEVITY
TB-500 molecular structure
No. 007
TB-500
REGEN
TESAMORELIN molecular structure
No. 008
TESAMORELIN
GROWTH
IPA / CJC-1295 molecular structure
No. 009
IPA / CJC-1295
GROWTH
MOTS-c molecular structure
No. 010
MOTS-c
METABOLICLONGEVITY
SELANK molecular structure
No. 011
SELANK
COGNITION
SEMAX molecular structure
No. 012
SEMAX
COGNITION
SS-31 molecular structure
No. 013
SS-31
LONGEVITYMETABOLIC
WOLVERINE molecular structure
No. 014
WOLVERINE
REGENMULTI
5-AMINO-1MQ molecular structure
No. 015
5-AMINO-1MQ
METABOLICLONGEVITY
ADAMAX molecular structure
No. 016
ADAMAX
REGENCOGNITION
IGF-1 LR3 molecular structure
No. 017
IGF-1 LR3
GROWTHMETABOLIC
AMYLIN RECEPTOR AGONIST molecular structure
No. 018
AMYLIN RECEPTOR AGONIST
METABOLIC
GLP-1 / GLUCAGON DUAL AGONIST molecular structure
No. 019
GLP-1 / GLUCAGON DUAL AGONIST
INCRETINMETABOLIC
ORAL GLP-1 RECEPTOR MIMETIC molecular structure
No. 020
ORAL GLP-1 RECEPTOR MIMETIC
INCRETIN
MAZDUTIDE molecular structure
No. 021
MAZDUTIDE
INCRETINMETABOLIC
PT-141 molecular structure
No. 022
PT-141
REGEN
EPITALON molecular structure
No. 023
EPITALON
LONGEVITY
GH FRAGMENT (LIPOLYTIC) molecular structure
No. 024
GH FRAGMENT (LIPOLYTIC)
METABOLICGROWTH
KISSPEPTIN-10 molecular structure
No. 025
KISSPEPTIN-10
GROWTH
THYMOSIN α-1 molecular structure
No. 026
THYMOSIN α-1
CYTOPROTECTION
HUMANIN molecular structure
No. 027
HUMANIN
LONGEVITY

▶ BROWSE BY MECHANISM

INCRETINMETABOLICREPAIRCYTOPROTECTIONANGIOGENESISACTINSKINLONGEVITYSIRTUINSMITOCHONDRIAEXERCISEGH-AXIS+ ALL MECHANISMS

▶ FEATURED STACKS

STACK

Classic Recovery

The most-referenced recovery stack in community protocols.

BPC-157 + TB-500

STACK

GH-Axis Trifecta

Three complementary upstream regulators of the GH pulse.

IPA-CJC1295 + TESAMORELIN

STACK

Skin & Matrix

Copper-peptide collagen induction plus pentadecapeptide angiogenesis.

GHK-CU + BPC-157

STACK

Cellular Bioenergetics

NAD+ + MOTS-c as a longevity-pathway research pair.

NAD-PLUS + MOTS-C

STACK

Incretin Comparison

the GLP-1 / GIP dual agonist + the triple-receptor incretin agonist reference framing (research only · never co-administered).

GLP1-GIP-DUAL-AGONIST + TRI-RECEPTOR-INCRETIN-AGONIST

STACK

Russian Heptapeptide Pair

Semax (BDNF / cognition) + Selank (GABAergic / anxiolytic).

SEMAX + SELANK

How this reference is built

Every compound entry is reviewed against a published rubric. Mechanism notes cite peer-reviewed literature. Evidence grades reflect the level of human-trial support, not commercial claims.

Methodology

A–F evidence grades

Each documented outcome is scored against the strength of the underlying human-trial record. A = Phase 3 RCT replication. F = animal-model only.

Read the grading rubric →

Editorial

Reviewer-signed entries

Each compound monograph is signed off against the published editorial process. Trade-name promotion is excluded from review.

Editorial policy →

Live updates

Daily PubMed index

A cron polls PubMed nightly for fresh papers on tracked compounds. New entries appear within 24h of indexing.

See latest papers →

Research Use Only

All material on this site documents the published research record only. GigaResearch does not recommend any human dose or administration route. Compounds documented here are not pharmaceutical products and are not a substitute for medical advice. Reference-grade material is supplied for in-vitro and laboratory research purposes only.

© 2026 GigaCompounds LLC · For Laboratory Research Use Only